Literature DB >> 34279775

Single-Nucleotide Polymorphism Associates' β-Tubulin Isotype-1 Gene in Onchocerca volvulus Populations in Ivermectin-Treated Communities in Taraba State, Nigeria.

Danlami E Akafyi1, Iliya S Ndams2,3, Ishaya H Nock2, Gloria Chechet4, Alfons Renz5.   

Abstract

PURPOSE: The occurrence of Single-Nucleotide Polymorphisms (SNPs) associated with repeated ivermectin treatment and sub-optimal responses reported by previous findings is of great concern in Onchocerciasis endemic areas. This study investigated SNPs' occurrence after 15 years of ivermectin intervention in Onchocerciasis endemic communities in two Local Government Areas of Taraba State, Nigeria.
METHODS: Microfilariae samples were collected by skin snip from individuals treated with ivermectin for 10-15 years of annual distribution and preserved in RNAlater® in a 1.5 ml micro-centrifuge tube. Genomic DNA was extracted from microfilariae and residual skin, amplification in two regions within the β-tubulin gene, sequenced and analyzed for SNPs using Bioinformatics tools.
RESULTS: Three distinct SNP positions: 1183 (T/G), 1188 (T/C) and 1308 (C/T) on the β-tubulin gene on the targeted 1083-1568 bp fragment, associate's with the ivermectin-treated population. Furthermore, SNPs positions detected in this study are 1730 (A/G) and 1794 (T/G) in the β-tub gene in the 1557-1857 (bp) region. The 1794 (T/G) SNP position (Phe243Val) in the exon within the β-tubulin gene region were observed in this study.
CONCLUSION: The present study indicates that SNPs are observed in Onchocerca volvulus, thus strengthening the warning that genetic changes could occur in some parasite populations in some ivermectin-treated areas.
© 2021. Witold Stefański Institute of Parasitology, Polish Academy of Sciences.

Entities:  

Keywords:  Ivermectin; Microfilaria; Onchocerciasis; Snps; β-tubulin

Mesh:

Substances:

Year:  2021        PMID: 34279775     DOI: 10.1007/s11686-021-00427-y

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  15 in total

1.  Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis.

Authors:  Magdi M M Ali; Moawia M Mukhtar; Omer Z Baraka; Mamoun M A Homeida; Musa M Kheir; Charles D Mackenzie
Journal:  Acta Trop       Date:  2002-10       Impact factor: 3.112

2.  The role of national committees in eliminating onchocerciasis.

Authors:  Emily Griswold; Thomas Unnasch; Mark Eberhard; Bertram E B Nwoke; Zoraida Morales; Edridah Muheki Tukahebwa; Biruck Kebede; Ifeoma Anagbogu; Moses Katabarwa; Peace Habomugisha; Zerihun Tadesse; Emmanuel S Miri; Darin Evans; Daniel Cohn; Elizabeth Elhassan; Frank Richards
Journal:  Int Health       Date:  2018-03-01       Impact factor: 2.473

3.  Phenotyping and genotyping of Haemonchus contortus isolates reveals a new putative candidate mutation for benzimidazole resistance in nematodes.

Authors:  Marc Ghisi; Ronald Kaminsky; Pascal Mäser
Journal:  Vet Parasitol       Date:  2006-11-13       Impact factor: 2.738

4.  Single nucleotide polymorphisms in β-tubulin selected in Onchocerca volvulus following repeated ivermectin treatment: possible indication of resistance selection.

Authors:  Hugues Nana-Djeunga; Catherine Bourguinat; Sébastien D S Pion; Joseph Kamgno; Jacques Gardon; Flobert Njiokou; Michel Boussinesq; Roger K Prichard
Journal:  Mol Biochem Parasitol       Date:  2012-06-05       Impact factor: 1.759

5.  Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.

Authors:  K Awadzi; S K Attah; E T Addy; N O Opoku; B T Quartey; J K Lazdins-Helds; K Ahmed; B A Boatin; D A Boakye; G Edwards
Journal:  Ann Trop Med Parasitol       Date:  2004-06

6.  Detection of Onchocerca volvulus in Skin Snips by Microscopy and Real-Time Polymerase Chain Reaction: Implications for Monitoring and Evaluation Activities.

Authors:  Elizabeth A Thiele; Vitaliano A Cama; Thomson Lakwo; Sindeaw Mekasha; Francisca Abanyie; Markos Sleshi; Amha Kebede; Paul T Cantey
Journal:  Am J Trop Med Hyg       Date:  2016-02-15       Impact factor: 2.345

7.  Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment.

Authors:  Mike Y Osei-Atweneboana; Daniel A Boakye; Kwablah Awadzi; John O Gyapong; Roger K Prichard
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-02-12       Impact factor: 4.077

8.  Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.

Authors:  Samuel Wanji; Jonas A Kengne-Ouafo; Mathias E Esum; Patrick W N Chounna; Bridget F Adzemye; Joan E E Eyong; Isaac Jato; Fabrice R Datchoua-Poutcheu; Raphael A Abong; Peter Enyong; David W Taylor
Journal:  Parasit Vectors       Date:  2015-12-30       Impact factor: 3.876

9.  Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.

Authors:  Lamine Diawara; Mamadou O Traoré; Alioune Badji; Yiriba Bissan; Konimba Doumbia; Soula F Goita; Lassana Konaté; Kalifa Mounkoro; Moussa D Sarr; Amadou F Seck; Laurent Toé; Seyni Tourée; Jan H F Remme
Journal:  PLoS Negl Trop Dis       Date:  2009-07-21

10.  The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.

Authors:  Honorat G M Zouré; Mounkaila Noma; Afework H Tekle; Uche V Amazigo; Peter J Diggle; Emanuele Giorgi; Jan H F Remme
Journal:  Parasit Vectors       Date:  2014-07-22       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.